Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV003129155 | SCV003805399 | uncertain significance | not provided | 2023-02-17 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV003162188 | SCV003875753 | uncertain significance | Inborn genetic diseases | 2023-01-25 | criteria provided, single submitter | clinical testing | The c.221C>A (p.A74D) alteration is located in exon 2 (coding exon 1) of the SCO2 gene. This alteration results from a C to A substitution at nucleotide position 221, causing the alanine (A) at amino acid position 74 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV004560093 | SCV005049389 | uncertain significance | Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 | 2024-01-24 | criteria provided, single submitter | clinical testing |